WS #10245
Unconfirmed claim that Eli Lilly hit $1T valuation on strong GLP-1 sales, potentially bullish for LLY and biotech sector. Australia confirms first H5N1 bird flu case, potentially impacting poultry and vaccine stocks but low near-term US market impact.
Eli Lilly valuation milestone
Unconfirmed claim that Eli Lilly hit $1T valuation on strong GLP-1 sales, potentially bullish for LLY and biotech sector.
Australia confirms first H5N1 bird flu case, potentially impacting poultry and vaccine stocks but low near-term US market impact.